Rhinitis, Allergic, Seasonal
85
0
1
79
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
21 trials with published results (25%)
Research Maturity
79 completed trials (93% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
3.5%
3 terminated out of 85 trials
96.3%
+9.8% vs benchmark
44%
37 trials in Phase 3/4
27%
21 of 79 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 79 completed trials
Clinical Trials (85)
An Exploratory Study of PQ Grass 27600 SU
A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.
Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study
A Dose-finding Study of ASP4070
Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)
An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)
An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)
Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)
Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever
Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.
Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma
Intralymphatic Immunotherapy in Increasing Doses, Substudy
Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)
Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)
Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)
Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)
The Effects of Phenylephrine Compared With Those of Placebo and Pseudoephedrine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis (SAR)(P04579)
Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)